| Metformin Hydrochloride 500 mg/5 ml Oral Solution PA23081/008/001 |
Metformin Hydrochloride |
Taw Pharma (Ireland) Limited |
Marketed |
| Methadone Hydrochloride 5 mg tablets PA23163/002/001 |
Methadone hydrochloride |
Ascot Laboratories (Ireland) Limited |
Not marketed |
| Methadone Hydrochloride Sugar Free 1 mg/1 ml Oral Solution PA23081/011/001 |
Methadone hydrochloride |
Taw Pharma (Ireland) Limited |
Marketed |
| Methofill 10 mg solution for injection in pre-filled injector PA2315/060/003 |
Methotrexate |
Accord Healthcare Ireland Ltd. |
Marketed |
| Methofill 12.5 mg solution for injection in pre-filled injector PA2315/060/004 |
Methotrexate |
Accord Healthcare Ireland Ltd. |
Marketed |
| Methofill 15 mg solution for injection in pre-filled injector PA2315/060/005 |
Methotrexate |
Accord Healthcare Ireland Ltd. |
Marketed |
| Methofill 17.5 mg solution for injection in pre-filled injector PA2315/060/006 |
Methotrexate |
Accord Healthcare Ireland Ltd. |
Marketed |
| Methofill 20 mg solution for injection in pre-filled injector PA2315/060/007 |
Methotrexate |
Accord Healthcare Ireland Ltd. |
Marketed |
| Methofill 22.5 mg solution for injection in pre-filled injector PA2315/060/008 |
Methotrexate |
Accord Healthcare Ireland Ltd. |
Marketed |
| Methofill 25 mg solution for injection in pre-filled injector PA2315/060/009 |
Methotrexate |
Accord Healthcare Ireland Ltd. |
Marketed |
| Methofill 27.5 mg solution for injection in pre-filled injector PA2315/060/010 |
Methotrexate |
Accord Healthcare Ireland Ltd. |
Marketed |
| Methofill 30 mg solution for injection in pre-filled injector PA2315/060/011 |
Methotrexate |
Accord Healthcare Ireland Ltd. |
Marketed |
| Methofill 50 mg/mL solution for injection in pre-filled syringe PA2315/060/001 |
Methotrexate |
Accord Healthcare Ireland Ltd. |
Not marketed |
| Methofill 7.5 mg solution for injection in pre-filled injector PA2315/060/002 |
Methotrexate |
Accord Healthcare Ireland Ltd. |
Marketed |
| Methotrexate 1 g/10 ml Injection PA0822/206/006 |
Methotrexate |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Methotrexate 10 mg tablets PA2315/062/002 |
Methotrexate |
Accord Healthcare Ireland Ltd. |
Marketed |
| Methotrexate 100 mg/ml concentrate for solution for infusion PA2315/061/002 |
Methotrexate |
Accord Healthcare Ireland Ltd. |
Not marketed |
| Methotrexate 2.5 mg tablets PA2315/062/001 |
Methotrexate |
Accord Healthcare Ireland Ltd. |
Marketed |
| Methotrexate 25 mg/ml Solution for Injection PA2315/061/001 |
Methotrexate |
Accord Healthcare Ireland Ltd. |
Not marketed |
| Methotrexate 5 g/50 ml Injection PA0822/206/007 |
Methotrexate |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Methotrexate 5 mg/2 ml Injection PA0822/206/001 |
Methotrexate |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Methotrexate Pfizer 50mg/2ml Injection PA0822/206/002 |
Methotrexate |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Metoclopramide 5mg/ml Solution for Injection PA0073/084/001 |
Metoclopramide hydrochloride |
Mercury Pharmaceuticals (Ireland) Ltd |
Marketed |
| Metoclopramide hydrochloride 10 mg tablets PA2315/204/001 |
Metoclopramide hydrochloride |
Accord Healthcare Ireland Ltd. |
Not marketed |
| Mezavant XL 1200 mg gastro-resistant, prolonged release tablets PA23211/004/001 |
Mesalazine |
Takeda Pharmaceuticals International AG Ireland Branch |
Marketed |
| Microlax Rectal Solution Sodium Citrate 450 mg/5 ml Sodium Lauryl Sulphoacetate 45 mg/5 ml PA23490/017/001 |
Sodium citrate, Sodium lauryl sulfoacetate |
JNTL Consumer Health I (Ireland) Limited |
Marketed |
| Midazolam 1 mg/ml Solution for Injection or Infusion PA2315/063/001 |
Midazolam |
Accord Healthcare Ireland Ltd. |
Marketed |
| Midazolam 1 mg/ml solution for injection/infusion in pre-filled syringe PA2315/220/001 |
Midazolam |
Accord Healthcare Ireland Ltd. |
Not marketed |
| Midazolam 2 mg/ml Solution for injection or infusion PA2315/063/005 |
Midazolam |
Accord Healthcare Ireland Ltd. |
Marketed |
| Midazolam 5 mg/ml Solution for injection or infusion PA2315/063/006 |
Midazolam |
Accord Healthcare Ireland Ltd. |
Marketed |
| Midazolam 5 mg/ml Solution for Injection or Infusion PA2315/063/002 |
Midazolam |
Accord Healthcare Ireland Ltd. |
Not marketed |
| Migraleve Film-coated Tablets PA23490/014/003 |
BUCLIZINE HYDROCHLORIDE, Paracetamol, Codeine phosphate hemihydrate |
JNTL Consumer Health (Ireland) Limited |
Marketed |
| Migraleve Pink Film-coated Tablets Paracetamol 500mg Codeine Phosphate 8mg Buclizine Hydrochloride 6.25mg PA23490/014/001 |
Paracetamol, BUCLIZINE HYDROCHLORIDE, Codeine phosphate bp |
JNTL Consumer Health (Ireland) Limited |
Marketed |
| Migraleve Yellow Film-coated Tablets Paracetamol 500mg Codeine phosphate 8mg PA23490/014/002 |
Paracetamol, Codeine phosphate hemihydrate |
JNTL Consumer Health I (Ireland) Limited |
Not marketed |
| Milk of Magnesia Traditional Mint Flavoured Liquid, 415 mg/5 ml oral suspension PA1186/010/001 |
Magnesium hydroxide |
Chefaro Ireland DAC, |
Marketed |
| MINESSE 60 micrograms/15 micrograms film-coated tablet PA0822/144/001 |
Gestodene, Ethinylestradiol |
Pfizer Healthcare Ireland Unlimited Company |
Not marketed |
| Minims Artificial Tears 0.35% w/w + 0.44% w/w Eye Drops, Solution PA23259/013/001 |
Sodium chloride, Hydroxyethylcellulose |
Bausch + Lomb Ireland Limited |
Not marketed |
| Minims Atropine Sulphate 1% Eye Drops, solution PA23259/007/001 |
Atropine sulfate |
Bausch + Lomb Ireland Limited |
Marketed |
| Minims Chloramphenicol 0.5% Eye Drops, Solution PA23259/010/001 |
Chloramphenicol |
Bausch + Lomb Ireland Limited |
Marketed |
| Minims Cyclopentolate Hydrochloride 1% w/v Eye Drops, solution PA23259/011/001 |
Cyclopentolate hydrochloride |
Bausch + Lomb Ireland Limited |
Not marketed |
| Minims Fluorescein Sodium 2%, w/v Eye Drops, Solution PA23259/012/002 |
Fluorescein sodium |
Bausch + Lomb Ireland Limited |
Marketed |
| Minims Lidocaine Hydrochloride 4% w/v & Fluorescein Sodium 0.25% w/v Eye Drops, solution PA23259/014/001 |
Fluorescein sodium, Lidocaine hydrochloride |
Bausch + Lomb Ireland Limited |
Marketed |
| Minims Oxybuprocaine Hydrochloride 0.4% w/v Eye Drops Solution PA23259/015/001 |
Oxybuprocaine hydrochloride |
Bausch + Lomb Ireland Limited |
Marketed |
| Minims Phenylephrine Hydrochloride 2.5% w/v eye drops, solution PA23259/016/001 |
Phenylephrine hydrochloride |
Bausch + Lomb Ireland Limited |
Marketed |
| Minims Pilocarpine Nitrate 2% w/v, Eye Drops, Solution PA23259/017/001 |
Pilocarpine nitrate |
Bausch + Lomb Ireland Limited |
Marketed |
| Minims Povidone Iodine 5% w/v Eye Drops, Solution PA23259/018/001 |
Iodinated povidone |
Bausch + Lomb Ireland Limited |
Marketed |
| Minims Prednisolone Sodium Phosphate 0.5% w/v Eye Drops, Solution PA23259/019/001 |
Prednisolone sodium phosphate |
Bausch + Lomb Ireland Limited |
Marketed |
| Minims Proxymetacaine hydrochloride 0.5% w/v, Eye Drops, Solution PA23259/020/001 |
PROXYMETACAINE HYDROCHLORIDE |
Bausch + Lomb Ireland Limited |
Marketed |
| Minims Saline 0.9% w/v Eye Drops, Solution PA23259/021/001 |
Sodium chloride |
Bausch + Lomb Ireland Limited |
Not marketed |
| Minims Tetracaine Hydrochloride 0.5% w/v Eye Drops, Solution PA23259/022/001 |
Tetracaine hydrochloride |
Bausch + Lomb Ireland Limited |
Not marketed |